These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9695999)

  • 21. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ; Bansky G
    Schweiz Med Wochenschr; 1990 Apr; 120(15):553-6. PubMed ID: 2159659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis.
    Goulenok C; Bernard B; Cadranel JF; Thabut D; Di Martino V; Opolon P; Poynard T
    Aliment Pharmacol Ther; 2002 Mar; 16(3):361-72. PubMed ID: 11876688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is flumazenil an alternative for the treatment of hepatic encephalopathy?
    Reyes D; Barrera F
    Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the therapeutic effect of flumazenil in hepatic encephalopathy using cerebral cartography].
    Bello Mimbrera G; García de León M; de la Torre Gutiérrez S; Montero Vázquez J; Torres Salcines J; de la Torre Fernández JM
    Rev Esp Enferm Apar Dig; 1989 Mar; 75(3):277-9. PubMed ID: 2499914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flumazenil: a benzodiazepine antagonist.
    Hoffman EJ; Warren EW
    Clin Pharm; 1993 Sep; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence.
    Urschel HC; Hanselka LL; Baron M
    J Psychopharmacol; 2011 Feb; 25(2):254-62. PubMed ID: 19939864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
    Ferenci P; Grimm G
    Adv Exp Med Biol; 1990; 272():255-65. PubMed ID: 2103692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
    Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
    Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.
    Gyr K; Meier R; Häussler J; Boulétreau P; Fleig WE; Gatta A; Holstege A; Pomier-Layrargues G; Schalm SW; Groeneweg M; Scollo-Lavizzari G; Ventura E; Zeneroli ML; Williams R; Yoo Y; Amrein R
    Gut; 1996 Aug; 39(2):319-24. PubMed ID: 8977350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J; Sittl R
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.
    Depew W; Boyer T; Omata M; Redeker A; Reynolds T
    Gastroenterology; 1980 Mar; 78(3):524-9. PubMed ID: 6985881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
    Saji S; Kumar S; Thomas V
    Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons.
    Ahboucha S; Coyne L; Hirakawa R; Butterworth RF; Halliwell RF
    Neurochem Int; 2006 Jun; 48(8):703-7. PubMed ID: 16487630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flumazenil in alcohol withdrawal.
    Nutt D; Glue P; Wilson S; Groves S; Coupland N; Bailey J
    Alcohol Alcohol Suppl; 1993; 2():337-41. PubMed ID: 7748321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.
    Amodio P; Marchetti P; Del Piccolo F; Beghi A; Comacchio F; Carraro P; Campo G; Baruzzo L; Marchiori C; Gatta A
    Clin Physiol; 1997 Sep; 17(5):533-9. PubMed ID: 9347201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake.
    Perney P; Butterworth RF; Mousseau DD; Lavoie J; Fabbro-Peray P; Blanc F; Layrargues GP
    Metab Brain Dis; 1998 Sep; 13(3):201-10. PubMed ID: 9804365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.